Determining treatment effectiveness and period of treatment
Article first published online: 19 OCT 2009
DOI: 10.1111/j.1440-1843.2009.01574.x
© 2009 The Japanese Respiratory Society. Journal compilation © 2009 Asian Pacific Society of Respirology
Issue

Respirology
Special Issue: The Japanese Respiratory Society Guidelines for the Management of Hospital-Acquired Pneumonia in Adults
Volume 14, Issue Supplement s2, pages S38–S40, November 2009
Additional Information
How to Cite
(2009), Determining treatment effectiveness and period of treatment. Respirology, 14: S38–S40. doi: 10.1111/j.1440-1843.2009.01574.x
Publication History
- Issue published online: 19 OCT 2009
- Article first published online: 19 OCT 2009
- Abstract
- Article
- References
- Cited By
SUMMARY
• Judging the effect of treatment for hospital-acquired pneumonia is difficult using only inflammatory parameters or findings from chest radiography.
• Preferably, treatment effects should be judged comprehensively from body temperature, findings of chest radiography, inflammatory parameters, status of purulent discharge, bacteriological findings and oxygenation.
• In VAP, the parameter most closely correlated with prognosis is trend in PaO2/FiO2.
• Clinical improvements are normally seen within 72 h. Antimicrobials thus should not be changed until the third day unless a dramatic deterioration in symptoms is seen.
• With the exception of pneumonia from microbes that tend to possess strong resistance, such as Pseudomonas aeruginosa, a treatment period of 7–10 days is adequate if the early-stage drugs are effective.
• If no improvements in the course are achieved by 3 days after starting treatment, an investigation should be made into whether treatment should be continued or changed to a different antimicrobial agent.

1440-1843/asset/RESP_left.gif?v=1&s=a110bec2019e1353a37e9b3af15908c01a36bc31)
1440-1843/asset/RESP_right.gif?v=1&s=2996c5a131272e16b9e97c7ece43b33e2548b8e2)